Emily E. Van Seventer

4.5k total citations
22 papers, 352 citations indexed

About

Emily E. Van Seventer is a scholar working on Oncology, Cancer Research and Physiology. According to data from OpenAlex, Emily E. Van Seventer has authored 22 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Cancer Research and 6 papers in Physiology. Recurrent topics in Emily E. Van Seventer's work include Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Nutrition and Health in Aging (6 papers). Emily E. Van Seventer is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Nutrition and Health in Aging (6 papers). Emily E. Van Seventer collaborates with scholars based in United States, Germany and Australia. Emily E. Van Seventer's co-authors include Ryan B. Corcoran, Aparna R. Parikh, Ryan David Nipp, Florian J. Fintelmann, Eric Roeland, Till D. Best, Rona Yaeger, Sebastián Mondaca, Daisuke Kotani and Jennifer S. Temel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Emily E. Van Seventer

20 papers receiving 349 citations

Peers

Emily E. Van Seventer
Emily E. Van Seventer
Citations per year, relative to Emily E. Van Seventer Emily E. Van Seventer (= 1×) peers Cédric Lecaille

Countries citing papers authored by Emily E. Van Seventer

Since Specialization
Citations

This map shows the geographic impact of Emily E. Van Seventer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Van Seventer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Van Seventer more than expected).

Fields of papers citing papers by Emily E. Van Seventer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily E. Van Seventer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Van Seventer. The network helps show where Emily E. Van Seventer may publish in the future.

Co-authorship network of co-authors of Emily E. Van Seventer

This figure shows the co-authorship network connecting the top 25 collaborators of Emily E. Van Seventer. A scholar is included among the top collaborators of Emily E. Van Seventer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily E. Van Seventer. Emily E. Van Seventer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heather, James, Daniel W. Kim, Emily E. Van Seventer, et al.. (2025). The differential immunological impact of photon vs proton radiation therapy in high-grade lymphopenia in patients with gastrointestinal tumors. Clinical & Experimental Immunology. 219(1).
2.
Saraf, Anurag, Islam Baiev, Emily E. Van Seventer, et al.. (2023). Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer. JAMA Network Open. 6(11). e2343512–e2343512. 5 indexed citations
3.
Loomans‐Kropp, Holli A., Yurong Song, Manish Gala, et al.. (2022). Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer. Cancer Research Communications. 2(2). 90–98. 24 indexed citations
4.
Nipp, Ryan David, Till D. Best, Emily E. Van Seventer, et al.. (2022). Associations of sarcopenia with hematologic toxicity, treatment intensity, and healthcare utilization in patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 40(4_suppl). 84–84. 1 indexed citations
5.
Best, Till D., Eric Roeland, Nora Horick, et al.. (2021). Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss. The Oncologist. 26(6). e963–e970. 18 indexed citations
6.
Roeland, Eric, Emily E. Van Seventer, Till D. Best, et al.. (2021). Percentile‐based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels. Journal of Cachexia Sarcopenia and Muscle. 13(1). 190–202. 21 indexed citations
7.
Esquivel, Mikaela, Emily E. Van Seventer, Li Zhang, et al.. (2021). Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation.. Journal of Clinical Oncology. 39(15_suppl). 3565–3565. 4 indexed citations
8.
Baiev, Islam, Emily E. Van Seventer, Amirkasra Mojtahed, et al.. (2021). Changes in patient-reported outcomes (PROs) and tumor markers (TMs) to predict treatment response and survival in patients with metastatic gastrointestinal (GI) cancer.. Journal of Clinical Oncology. 39(28_suppl). 154–154. 1 indexed citations
9.
Seventer, Emily E. Van, Till D. Best, Nora Horick, et al.. (2020). Relationships among skeletal muscle, symptom burden, health care use, and survival in hospitalized patients with advanced cancer.. Journal of Clinical Oncology. 38(15_suppl). 7006–7006. 1 indexed citations
10.
Seventer, Emily E. Van, Florian J. Fintelmann, Eric Roeland, & Ryan David Nipp. (2020). Leveraging the Potential Synergy Between Patient-Reported Outcomes and Body Composition Analysis in Patients with Cancer. The Oncologist. 25(4). 271–273. 7 indexed citations
11.
Roeland, Eric, Katie Kanter, Jennifer Y. Wo, et al.. (2020). Preliminary analysis of total neoadjuvant therapy for patients with locally advanced gastric (G) and gastroesophageal (GE) adenocarcinoma.. Journal of Clinical Oncology. 38(4_suppl). 393–393. 1 indexed citations
12.
Bitterman, Danielle S., Kristin S. Price, Emily E. Van Seventer, et al.. (2020). Noninvasive comprehensive genomic profiling from plasma ctDNA in pancreatic cancer patients.. Journal of Clinical Oncology. 38(4_suppl). 753–753. 1 indexed citations
13.
Kamran, Sophia C., Jochen K. Lennerz, Claire A. Margolis, et al.. (2019). Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer. Clinical Cancer Research. 25(18). 5561–5571. 62 indexed citations
14.
Yaeger, Rona, Daisuke Kotani, Sebastián Mondaca, et al.. (2019). Response to Anti-EGFR Therapy in Patients with BRAF non-V600–Mutant Metastatic Colorectal Cancer. Clinical Cancer Research. 25(23). 7089–7097. 85 indexed citations
15.
Hartwig, Anna, Carlo G. Artieri, Ariel Jaimovich, et al.. (2019). Analytical validation of a tumor-agnostic integrated multianalyte circulating tumor DNA (ctDNA) assay in early-stage cancer.. Journal of Clinical Oncology. 37(15_suppl). 3057–3057.
16.
Maruvka, Yosef E., Jonna Grimsby, Emily E. Van Seventer, et al.. (2019). Abstract A094: MSIClass - Identification and classification of microsatellite unstable tumors using cell-free DNA from ultra low pass sequencing. Molecular Cancer Therapeutics. 18(12_Supplement). A094–A094. 1 indexed citations
17.
Corcoran, Ryan B., T. Khanh, James M. Cleary, et al.. (2019). Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours. Annals of Oncology. 30. v164–v164. 16 indexed citations
18.
Parikh, Aparna R., Emily E. Van Seventer, Genevieve M. Boland, et al.. (2019). A plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay to inform recurrence risk in colorectal cancer (CRC).. Journal of Clinical Oncology. 37(15_suppl). 3602–3602. 14 indexed citations
19.
Troschel, Fabian M., Till D. Best, Henning A. Gaissert, et al.. (2019). Computed Tomography–based Body Composition Analysis and Its Role in Lung Cancer Care. Journal of Thoracic Imaging. 35(2). 91–100. 50 indexed citations
20.
Chatterjee, Soumya, Kawsar R. Talaat, Emily E. Van Seventer, et al.. (2017). Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages. PLoS ONE. 12(6). e0179701–e0179701. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026